GWM
RDY icon

Gitterman Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Gitterman Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$245K Buy
17,512
+1,675
+11% +$24.1K 0.06% 105
2025
Q2 		$238K Sell
15,837
-367
-2% -$5.24K 0.06% 112
2025
Q1 		$214K Buy
16,204
+280
+2% +$3.86K 0.06% 111
2024
Q4 		$251K Buy
15,924
+1,104
+7% +$16.6K 0.11% 89
2024
Q3 		$236K Buy
14,820
+240
+2% +$3.86K 0.1% 92
2024
Q2 		$222K Buy
+14,580
New +$209K 0.09% 90

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gitterman Wealth Management's RDY Position: Q3 2025 in Review

Gitterman Wealth Management increased its Dr. Reddy's Laboratories (RDY) stake by 11% in Q3 2025, buying an estimated $24.1K and bringing the position to 17,512 shares worth $245K. The position accounts for 0.06% of the portfolio, ranked #105.

Gitterman Wealth Management first reported a position in RDY in Q2 2024 and has held it in 6 quarters since. The position peaked at $251K in Q4 2024. 227 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

  • Gitterman Wealth Management held 17,512 shares of Dr. Reddy's Laboratories worth $245K as of Q3 2025.
  • Gitterman Wealth Management bought 1,675 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $24.1K.
  • Dr. Reddy's Laboratories made up 0.06% of Gitterman Wealth Management's portfolio in Q3 2025, its #105 holding.
  • Gitterman Wealth Management first reported a position in Dr. Reddy's Laboratories in Q2 2024 and has held it in 6 quarters since.
  • Gitterman Wealth Management's Dr. Reddy's Laboratories position peaked at $251K in Q4 2024.
  • 227 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on Gitterman Wealth Management's 13F filing for Q3 2025, filed 4 Nov 2025.